River BioMedics paves the way to the future of cardiac drug discovery

Closer to the heart

We build high-throughput predictive 3D human cardiac disease models, combining our skills and expertise in engineering and human induced pluripotent stem cells (hiPSC)

Human induced pluripotent stem cell technology 

High human predictability

Healthy and disease cardiac models

High-throughput scalable screening platforms

Highly versatile custom-made shapes and co-cultures

Detailed clinically relevant read-outs

We empower novelty

We develop in full flow

We mimic nature

We connect biology and engineering

We value partnership

We listen to our customers

3D human cardiac models for

Compound screening

We provide a compound screening service for target validation and drug discovery. In close collaboration with our customers we develop custom-made 3D heart models that can be implemented in the pre-clinical phases of drug discovery and development.

Meet the team

We take on the challenge to bring cardiac drug development to the next level

Marcelo Ribeiro

Scientific and corporate development

Co-founder

Lisanne Blauw

Business and corporate development

Co-founder

Robert Passier

Scientific advisor

Co-founder

John Verhoeven

Business strategy advisor

Recent News

Read More